Open AccessClinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery
Author(s) -
Josephine S. Kim,
Margaret Liang,
Emily Prendergast,
Jill Alldredge,
Avisek Datta,
Jean Hurteau,
Carolyn V. Kirschner,
Gustavo C. Rodriguez,
Tilley Jenkins Vogel,
Rebecca Brooks,
Ilana Cass,
Joshua G. Cohen,
K. Penner,
Chi E. Wang,
Elena S. Diaz Moore
Publication year - 2019
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1136/ijgc-2019-000374
Subject(s) - medicine , chemotherapy , retrospective cohort study , surgery , ovarian cancer , cancer , oncology , neoadjuvant therapy , stage (stratigraphy) , breast cancer , paleontology , biology
To compare clinical outcomes for stage IIIC and IV ovarian cancer patients receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to three versus more cycles of post-operative chemotherapy.